Evaluation of a pharmaceutical care model on diabetes management

Annals of Pharmacotherapy

Volumn 30, Issue 3, 1996, Pages 238-243

  Jaber, Linda A ^a   Halapy, Henry ^b   Fernet, Mireille ^a   Tummalapalli, Suresh ^c   Diwakaran, Hariharan ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b Department of Pharmacy Practice ^*

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROPAMIDE; CHOLESTEROL; CREATININE; GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIET THERAPY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHARMACIST; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OUTPATIENT CLINICS, HOSPITAL; PATIENT EDUCATION; PHARMACY SERVICE, HOSPITAL; QUALITY OF LIFE; URBAN POPULATION;

EID: 0029872396     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000305     Document Type: Article

References (24)

1. American Hospital Association hospital statistics. 1990-1991 ed. Chicago: American Hospital Association, 1990.
2. Raehl C, Bond CA, Pitterle M. Ambulatory pharmacy services affiliated with acute care hospitals. Pharmacothcrapy 1993;13:618-25.
3. Carter BL, Helling DK Ambulatory care pharmacy services: the incomplete agenda. Ann Pharmacother 1992;26:701-8.
4. Lobas NH, Lepinski PW, Abramowitz PW. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic. Am J Hosp Pharm 1992;49:1681-8.
5. Chrischilles EA, Heliing DK, Aschoff CR. Effect of clinical pharmacy services on the quality of family practice physicians prescribing and medication costs. DICP Ann Pharmacother 1989;23:417-21.
6. Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost-justification of a clinical pharmacist-managed anticoagulation clinic. Drug Intell Clin Pharm 1985,19, 575-80.
7. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control: a four-year analysis of an ambulatory care model. Arch Intern Med 1984;144:1159-62.
8. McKenney JM, Witherspoon JM. The impact of outpatient hospital pharmacists on patients receiving antihypertensive and anticoagulant therapy. Hosp Pharm 1985;20:406-15.
9. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 1987;36:523-34.
10. American Diabetes Association. Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. Diabetes Care 1994;11:1357-61.
11. Huff PS, Ives TJ, Almond SN, Griffin NW. Pharmacist-managed diabetes education services. Am J Hosp Pharm 1983;40:991-4.
12. Schilling KW. Pharmacy program for monitoring diabetic patients. Am J Hosp Pharm 1977;34:1242-5.
13. Hawkins DW, Fiedler FP, Douglas HL, Eschbach RC. Evaluation of clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979;36:1321-5
14. Sczupak CA, Conrad WF. Relationship between patient-oriented pharmaceutical services and therapeutic outcomes of ambulatory patients with diabetes mellitus. Am J Hosp Pharm 1977;34:1238-42.
15. Van Veldhuizen MK, Popovich NG. Development and implementation of a pharmaceutical care model for diabetes patients in an ambulatory care setting (abstract). Proceedings of Annual Meeting of the American Pharmaceutical Association, Seattle, WA, March 1994.
16. Helper CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
17. Rowe DJF, Dawnay A, Watts GF. Microalbummuria recommendations for the measurement of albumin in urine. Ann Clin Biochcm 1990;27:297-312.
18. Health status questionnaire 2.0 user guide. Bloomington, MN: Health Outcomes Institute, 1993
19. Weinberger M, Kirkman MS, Samsa GP, Cowper PA, Shorthffe EA, Simel DL, et al The relationship between glycemic control and health-related quality of life in patients with non-insulm-dependent diabetes mellitus. Med Care 1994;32:1173-81.
20. Jacobson AM, De Groot M, Samson JA The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994;17:267-74.
21. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 1993;329:977-86.
22. Rubin RR, Peyrot M. Implications of the DCCT: looking beyond tight control. Diabetes Care 1994;17:235-6.
23. Raisch DW. Barriers to providing cognitive services. Am Pharm 1993;NS33:54-8.
24. McKenney JM, Slining JM, Henderson HR, Devins D, Barr M. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 1973;48:1104-11.